Panés, Julián
Rimola, Jordi
Article History
First Online: 9 August 2017
Competing interests
: J.P. has received consulting fees from Abbvie, Almirall, Boehringer-Ingelheim, Celgene, Ferring, Janssen, MSD, Novartis, Pfizer, Robarts, Roche, Second Genome, Shire, Takeda, TiGenix and Topivert; and speaker fees from Abbvie, Biogen, Ferring, Janssen, MSD and Pfizer. J.R. has received consulting and speaker fees from Abbvie, Bioclinica, Boehringer-Ingelheim, MSD, Robarts Clinical Trials, Roche, Takeda, and TiGenix.